Diabetes Detection, second-generation pager prototype is preparing to go to clinical trials.

September 11, 2007 - Hathaway Corporation (HWYI), a company that focuses on acquiring, developing, and managing disruptive technologies in the telecommunications, medical devices, and software fields that change the way companies grow and service their business globally, has announced that its subsidiary, Diabetes Detection Inc. (DDI), has completed its second-generation pager prototype, and is preparing to go to clinical trials. DDI is a next-generation medical device company addressing the Diabetes epidemic worldwide through the diagnosis and monitoring of Neuropathy -- an early sign of Diabetes... read the press release -